Evidence map›Paper›PMID 30728285›Full record

ArticleScience translational medicine2019

Recurrent group A

Jennifer M Dan, Colin Havenar-Daughton, Kayla Kendric, Rita Al-Kolla, Kirti Kaushik, Sandy L Rosales, Ericka L Anderson, Christopher N LaRock, Pandurangan Vijayanand, Grégory Seumois and 9 more

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 119 citations in OpenAlex.

  1. Trial
  2. CD9Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. T cells in Group AFrontiers in cellular and infection microbiology · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Jennifer M DanDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.ORCID 0000-0002-1672-0657
Colin Havenar-DaughtonDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.ORCID 0000-0002-2880-3927
Kayla KendricDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Rita Al-KollaDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Kirti KaushikDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Sandy L RosalesDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Ericka L AndersonDepartment of Pediatrics, School of Medicine, UCSD, La Jolla, CA 92037, USA.
Christopher N LaRockDepartment of Pediatrics, School of Medicine, UCSD, La Jolla, CA 92037, USA.ORCID 0000-0003-3035-5331
Pandurangan VijayanandDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.ORCID 0000-0001-7067-9723
Grégory SeumoisDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.ORCID 0000-0002-8164-6852
David LayfieldCancer Sciences Division, Faculty of Medicine, University of Southampton, UK.
Ramsey I CutressCancer Sciences Division, Faculty of Medicine, University of Southampton, UK.
Christian H OttensmeierCancer Sciences Division, Faculty of Medicine, University of Southampton, UK.ORCID 0000-0003-3619-1657
Cecilia S Lindestam ArlehamnDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.ORCID 0000-0001-7302-8002
Alessandro SetteDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.ORCID 0000-0001-7013-2250
Victor NizetDepartment of Pediatrics, School of Medicine, UCSD, La Jolla, CA 92037, USA.ORCID 0000-0003-3847-0422
Marcella BothwellDivision of Pediatric Otolaryngology, Rady Children's Hospital, San Diego, CA 92123, USA.ORCID 0000-0001-9771-6221
Matthew BriggerDivision of Pediatric Otolaryngology, Rady Children's Hospital, San Diego, CA 92123, USA.ORCID 0000-0002-3528-1696
Shane CrottyDivision of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA. shane@lji.org.ORCID 0000-0002-6484-6262
La Jolla Institute for Immunology · USUniversity of Southampton · GBInternational AIDS Vaccine Initiative · USNaval Medical Center San Diego · USUniversity of California San Diego · USEmory Healthcare · US

Funding

Support Component D/Vaccine Discovery, Concept to ClinicUM1AI100663 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI BAROUCH, DAN H. · 2012 to 2018
$131.5M
HOPE Training GrantT32AI007384 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sara Gianella Weibel, Scott L Letendre · 1990 to 2026
$9.7M
RESEARCH IN INFECTIOUS DISEASEST32AI007036 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 1985 to 2025
$9.2M
GAS Switch from Colonizing Bacterium to Invasive PathogenR01AI077780 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 2008 to 2019
$3.8M
CD4 T cell, germinal center, and antibody response defects in recurrent tonsillitisR01AI135193 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROTTY, SHANE P · 2018 to 2022
$2.3M
The Immunology of Recurrent Group A Streptococcus TonsillitisK08AI135078 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAN, JENNIFER MARIE · 2018 to 2022
$972k
Illumina HiSeq 2500 Sequencing SystemS10OD016262 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI RAO, ANJANA · 2013 to 2013
$600k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
Cancer Research UK 15951Medical Research Council MR/P024351/1NCRR NIH HHS S10 RR027366NIAID NIH HHS K08 AI135078NIAID NIH HHS L40 AI126497NIAID NIH HHS R01 AI077780NIAID NIH HHS R01 AI135193NIAID NIH HHS T32 AI007036NIAID NIH HHS T32 AI007384NIAID NIH HHS UM1 AI100663NIH HHS S10 OD016262
6 · The paper itself

Abstract

"Strep throat" is highly prevalent among children, yet it is unknown why only some children develop recurrent tonsillitis (RT), a common indication for tonsillectomy. To gain insights into this classic childhood disease, we performed phenotypic, genotypic, and functional studies on pediatric group A

Indexed as

AdolescentAllelesAntibodies, BacterialB-LymphocytesCell DifferentiationChildDisease SusceptibilityFemaleGerminal CenterGranzymesHistocompatibility Antigens Class IIHumansImmunoglobulin GMaleRecurrenceStreptococcusAntibodies, BacterialGranzymesHistocompatibility Antigens Class IIImmunoglobulin GSuperantigens

Identifiers

PMID30728285
PMCPMC6561727
OpenAlexW2810461543

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.